3 Biotech Stocks That I Won't Buy
One Motley Fool shares the three biotech stocks he can't justify buying for his portfolio.
Amarin Corporation PLC Shares Lifted Off in May -- Here's Why
Amarin gets investors' hearts racing with a favorable legal ruling regarding its lead drug, Vascepa. Find out what this ruling could mean for Amarin and its investors.